ProfileGDS5678 / 1445365_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 63% 59% 59% 59% 60% 61% 57% 59% 62% 57% 60% 59% 59% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.7723463
GSM967853U87-EV human glioblastoma xenograft - Control 23.5443859
GSM967854U87-EV human glioblastoma xenograft - Control 33.5396959
GSM967855U87-EV human glioblastoma xenograft - Control 43.5080859
GSM967856U87-EV human glioblastoma xenograft - Control 53.5274460
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.7390661
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5410657
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.5286159
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.6897162
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4441957
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.5913160
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.5328859
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5352859
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.5042858